Country: United States
Language: English
Source: NLM (National Library of Medicine)
OMEPRAZOLE (UNII: KG60484QX9) (OMEPRAZOLE - UNII:KG60484QX9)
AvKARE
ORAL
PRESCRIPTION DRUG
Omeprazole delayed-release capsules are indicated for short-term treatment of active duodenal ulcer in adults. Most patients heal within four weeks. Some patients may require an additional four weeks of therapy. Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence. Triple Therapy Omeprazole delayed-release capsules in combination with clarithromycin and amoxicillin, are indicated for treatment of patients with H. pylori infection and duodenal ulcer disease (active or up to 1-year history) to eradicate H. pylori in adults. Dual Therapy Omeprazole delayed-release capsules in combination with clarithromycin are indicated for treatment of patients with H. pylori infection and duodenal ulcer disease to eradicate H. pylori in adults. Among patients who fail therapy, omeprazole delayed-release capsules with clarithromycin are more likely to be associated with the development of clarithromycin resistance as compared with triple therapy. In patients who fail thera
Omeprazole delayed-release capsules, USP 10 mg are available for oral administration as hard gelatin capsules with a pink opaque body and a reddish brown opaque cap. “APO 010” is imprinted on each capsule in black ink. Omeprazole delayed-release capsules, USP 20 mg are available for oral administration as hard gelatin capsules with a pink opaque body and a reddish brown opaque cap. “APO 020” is imprinted on each capsule in black ink. They are supplied as follows: Bottles of 1000 (NDC 42291-572-10) Omeprazole delayed-release capsules, USP 40 mg are available for oral administration as hard gelatin capsules with a pink opaque body and a reddish brown opaque cap. “APO 040” is imprinted on each capsule in black ink. They are supplied as follows: Bottles of 1000 (NDC 42291-573-10) Storage Store omeprazole delayed-release capsules in a tight container protected from light and moisture. Store at 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
Abbreviated New Drug Application
AvKARE ---------- MEDICATION GUIDE Omeprazole Delayed-Release Capsules, USP (oh mep’ ra zole) Read this Medication Guide before you start taking omeprazole delayed-release capsules and each time you get a refill. There may be new information. This information does not take the place of talking with your doctor about your medical condition or your treatment. What is the most important information I should know about omeprazole delayed-release capsules? Omeprazole delayed-release capsules may help your acid-related symptoms, but you could still have serious stomach problems. Talk with your doctor. Omeprazole delayed-release capsules can cause serious side effects, including: • A type of kidney problem (acute interstitial nephritis). Some people who take proton pump inhibitor (PPI) medicines, including omeprazole, may develop a kidney problem called acute interstitial nephritis that can happen at any time during treatment with omeprazole. Call your doctor if you have a decrease in the amount that you urinate or if you have blood in your urine. • Diarrhea. Omeprazole may increase your risk of getting severe diarrhea. This diarrhea may be caused by an infection ( Clostridium difficile) in your intestines. Call your doctor right away if you have watery stool, stomach pain, and fever that does not go away. • Bone fractures. People who take multiple daily doses of PPI medicines for a long period of time (a year or longer) may have an increased risk of fractures of the hip, wrist, or spine. You should take omeprazole delayed-release capsules exactly as prescribed, at the lowest dose possible for your treatment and for the shortest time needed. Talk to your doctor about your risk of bone fracture if you take omeprazole delayed-release capsules. • Certain types of lupus erythematosus. Lupus erythematosus is an autoimmune disorder (the body’s immune cells attack other cells or organs in the body). Some people who take proton PPI medicines, including omeprazole, may develop certain types of lupus erythematosus or Read the complete document
OMEPRAZOLE- OMEPRAZOLE CAPSULE, DELAYED RELEASE AVKARE ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP RX ONLY THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE OMEPRAZOLE DELAYED- RELEASE CAPSULES SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR OMEPRAZOLE DELAYED-RELEASE CAPSULES. OMEPRAZOLE DELAYED-RELEASE CAPSULES, FOR ORAL USE INITIAL U.S. APPROVAL: 1989 RECENT MAJOR CHANGES Warnings and Precautions, Fundic Gland Polyps ( 5.12) 01/2018 INDICATIONS AND USAGE Omeprazole is a proton pump inhibitor (PPI) indicated for the: Treatment of active duodenal ulcer in adults ( 1.1) Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer recurrence in adults ( 1.2) Treatment of active benign gastric ulcer in adults ( 1.3) Treatment of symptomatic gastroesophageal reflux disease (GERD) in patients 1 year of age and older ( 1.4) Treatment of erosive esophagitis (EE) due to acid-mediated GERD in patients 1 month of age and older ( 1.5) Maintenance of healing of EE due to acid-mediated GERD in patients 1 year of age and older ( 1.6) Pathologic hypersecretory conditions in adults ( 1.7) DOSAGE AND ADMINISTRATION INDICATION RECOMMENDED ADULT ( 2.1) AND PEDIATRIC DOSAGE ( 2.2) Treatment of Active Duodenal Ulcer 20 mg once daily for 4 weeks; some patients may require an additional 4 weeks ( 2.1) _H. pylori_ Eradication to Reduce the Risk of Duodenal Ulcer Recurrence _Triple Therapy_: Omeprazole 20 mg Each drug twice daily for 10 days ( 2.1)* Amoxicillin 1000 mg Clarithromycin 500 mg _Dual Therapy:_ Omeprazole 40 mg once daily for 14 days** Clarithromycin 500 mg three times daily for 14 days ( 2.1) Active Benign Gastric Ulcer 40 mg once daily for 4 to 8 weeks ( 2.1) Symptomatic GERD 20 mg once daily for up to 4 weeks ( 2.1) See full prescribing information for weight based dosing in pediatric patients 1 year of age and older ( 2.2) EE due to Acid-Mediated GERD 20 mg once daily for 4 to 8 weeks ( 2.1)*** See full prescribing information for weigh Read the complete document